Document And Entity Information
Document And Entity Information - shares | 3 Months Ended | |
Mar. 31, 2023 | May 16, 2023 | |
Document Information Line Items | ||
Entity Registrant Name | Global Partner Acquisition Corp II | |
Document Type | 10-Q | |
Current Fiscal Year End Date | --12-31 | |
Amendment Flag | false | |
Entity Central Index Key | 0001831979 | |
Entity Current Reporting Status | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Document Period End Date | Mar. 31, 2023 | |
Document Fiscal Year Focus | 2023 | |
Document Fiscal Period Focus | Q1 | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Entity Shell Company | true | |
Entity Ex Transition Period | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Entity File Number | 001-39875 | |
Entity Incorporation, State or Country Code | E9 | |
Entity Tax Identification Number | 00-0000000 | |
Entity Address, Address Line One | 200 Park Avenue | |
Entity Address, Address Line Two | 32nd Floor | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10166 | |
City Area Code | (646) | |
Local Phone Number | 585-8975 | |
Entity Interactive Data Current | Yes | |
Units, each consisting of one Class A ordinary share, $.0001 par value, and one-sixth of one redeemable warrant | ||
Document Information Line Items | ||
Trading Symbol | GPACU | |
Title of 12(b) Security | Units, each consisting of one Class A ordinary share, $.0001 par value, and one-sixth of one redeemable warrant | |
Security Exchange Name | NASDAQ | |
Class A Ordinary Shares | ||
Document Information Line Items | ||
Trading Symbol | GPAC | |
Entity Common Stock, Shares Outstanding | 3,931,719 | |
Title of 12(b) Security | Class A ordinary shares | |
Security Exchange Name | NASDAQ | |
Redeemable Warrants | ||
Document Information Line Items | ||
Trading Symbol | GPACW | |
Title of 12(b) Security | Redeemable warrants | |
Security Exchange Name | NASDAQ | |
Class B Ordinary Shares | ||
Document Information Line Items | ||
Entity Common Stock, Shares Outstanding | 7,500,000 |
Condensed Balance Sheets
Condensed Balance Sheets - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Current assets - | ||
Cash | $ 3,000 | $ 101,000 |
Prepaid expenses | 206,000 | 8,000 |
Total current assets | 209,000 | 109,000 |
Investments held in Trust Account | 40,996,000 | 304,675,000 |
Total assets | 41,205,000 | 304,784,000 |
Current liabilities– | ||
Accounts payable | 11,000 | 75,000 |
Promissory Note – related party | 755,000 | 785,000 |
Extension Promissory Notes – related party, at fair value | 604,000 | |
Accrued liabilities | 828,000 | 3,016,000 |
Total current liabilities | 2,198,000 | 3,876,000 |
Other liabilities – | ||
Warrant liability | 2,357,000 | 467,000 |
Deferred underwriting commission | 10,500,000 | 10,500,000 |
Total liabilities | 15,055,000 | 14,843,000 |
Commitments and contingencies | ||
Class A ordinary shares subject to possible redemption; 3,931,719 and 30,000,000 shares, respectively,(at approximately $10.42 per share at March 31, 2023 and $10.15 per share at December 31, 2021) | 40,996,000 | 304,675,000 |
Shareholders’ deficit: | ||
Preference shares, $0.0001 par value; 5,000,000 shares authorized, none issued or outstanding | ||
Class A ordinary shares, $0.0001 par value, 500,000,000 authorized shares, -0- issued and outstanding (excluding 30,000,000 shares subject to possible redemption) | ||
Class B ordinary shares, $0.0001 par value, 50,000,000 authorized shares, 7,500,000 shares issued and outstanding | 1,000 | 1,000 |
Additional paid-in-capital | ||
Accumulated deficit | (14,847,000) | (14,735,000) |
Total shareholders’ deficit | (14,846,000) | (14,734,000) |
Total liabilities, Class A ordinary shares subject to possible redemption and shareholders’ deficit | $ 41,205,000 | $ 304,784,000 |
Condensed Balance Sheets (Paren
Condensed Balance Sheets (Parentheticals) - $ / shares | Mar. 31, 2023 | Dec. 31, 2022 |
Ordinary shares subject to possible redemption | 3,931,719 | 30,000,000 |
ordinary shares subject to possible redemption, per share (in Dollars per share) | $ 10.42 | $ 10.15 |
Preference shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preference shares, shares authorized | 5,000,000 | 5,000,000 |
Preference shares, shares issued | ||
Preference shares, shares outstanding | ||
Class A Ordinary Shares | ||
Ordinary shares subject to possible redemption | 3,931,719 | 30,000,000 |
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, authorized | 500,000,000 | 500,000,000 |
Ordinary shares, issued | 0 | 0 |
Ordinary shares, outstanding | 0 | 0 |
Class B Ordinary Shares | ||
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, authorized | 50,000,000 | 50,000,000 |
Ordinary shares, issued | 7,500,000 | 7,500,000 |
Ordinary shares, outstanding | 7,500,000 | 7,500,000 |
Condensed Statements of Operati
Condensed Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
General and administrative expenses | $ 1,078,000 | $ 191,000 |
Settlement and release of liabilities | (2,961,000) | |
Income (loss) from operations | 1,883,000 | (191,000) |
Income from cash and investments held in Trust Account | 921,000 | 25,000 |
Write off contingent warrants associated with shares redeemed | 130,000 | |
Change in fair value of Extension Promissory Notes – related party | (32,000) | |
Change in fair value of warrant liability | (2,020,000) | 6,849,000 |
Net income | $ 882,000 | $ 6,683,000 |
Class A Ordinary Shares | ||
Weighted average shares outstanding– basic and diluted (in Shares) | 7,118,000 | 30,000,000 |
Net income per ordinary share – basic and diluted (in Dollars per share) | $ 0.06 | $ 0.18 |
Class B Ordinary Shares | ||
Weighted average shares outstanding– basic and diluted (in Shares) | 7,500,000 | 7,500,000 |
Net income per ordinary share – basic and diluted (in Dollars per share) | $ 0.06 | $ 0.18 |
Condensed Statements of Opera_2
Condensed Statements of Operations (Unaudited) (Parentheticals) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Class A Ordinary Shares | ||
Weighted average shares outstanding - diluted | 7,118,000 | 30,000,000 |
Net income per ordinary share – diluted | $ 0.06 | $ 0.18 |
Class B Ordinary Shares | ||
Weighted average shares outstanding - diluted | 7,500,000 | 7,500,000 |
Net income per ordinary share – diluted | $ 0.06 | $ 0.18 |
Condensed Statements of Changes
Condensed Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($) | Class B Ordinary Shares | Additional Paid-in Capital | Accumulated Deficit | Total |
Balances at Dec. 31, 2021 | $ 1,000 | $ (25,129,000) | $ (25,128,000) | |
Balances (in Shares) at Dec. 31, 2021 | 7,500,000 | |||
Net income | 6,683,000 | 6,683,000 | ||
Balances at Mar. 31, 2022 | $ 1,000 | (18,446,000) | (18,445,000) | |
Balances (in Shares) at Mar. 31, 2022 | 7,500,000 | |||
Balances at Dec. 31, 2022 | $ 1,000 | (14,735,000) | (14,734,000) | |
Balances (in Shares) at Dec. 31, 2022 | 7,500,000 | |||
Accretion in value of Class A ordinary shares subject to redemption to redemption | (1,371,000) | (1,371,000) | ||
Inception date fair value adjustments of Extension Promissory Notes - related party | 377,000 | 377,000 | ||
Net income | 882,000 | 882,000 | ||
Balances at Mar. 31, 2023 | $ 1,000 | $ (14,847,000) | $ (14,846,000) | |
Balances (in Shares) at Mar. 31, 2023 | 7,500,000 |
Condensed Statements of Cash Fl
Condensed Statements of Cash Flows (unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Cash Flows [Abstract] | ||
Net income | $ 882,000 | $ 6,683,000 |
Adjustments to reconcile net income to net cash used in operating activities | ||
Income from cash and investments held in Trust Account | (921,000) | (25,000) |
Change in fair value of Extension Promissory Notes – related party | 32,000 | |
Change in fair value of warrant liability | 1,890,000 | (6,849,000) |
Increase in prepaid expenses | (198,000) | (8,000) |
(Decrease) increase in accounts payable | (64,000) | (109,000) |
Increase (decrease) in accrued liabilities | (2,188,000) | (6,000) |
Net cash used in operating activities | (567,000) | (314,000) |
Cash flows from investing activities: | ||
Cash deposited in Trust Account | (450,000) | |
Cash withdrawn from Trust Account | 265,050,000 | |
Net cash provided by investing activities | 264,600,000 | |
Cash flows from financing activities: | ||
Redemption of 26,068,281 Class A common shares | (265,050,000) | |
Repayment of Promissory Note – related party | (30,000) | |
Proceeds of Extension Promissory Note – related party | 949,000 | |
Net cash used in financing activities | (264,131,000) | |
Net change in cash | (98,000) | (314,000) |
Cash at beginning of the year | 101,000 | 842,000 |
Cash at end of the year | 3,000 | 528,000 |
Supplemental disclosure of non-cash financing activities: | ||
Deferred underwriter compensation | 10,500,000 | |
Offering costs included in accounts payable | $ 70,000 |
Condensed Statements of Cash _2
Condensed Statements of Cash Flows (unaudited) (Parentheticals) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Cash Flows [Abstract] | ||
Redemption of common shares | 26,068,281 | 26,068,281 |
Description of Organization and
Description of Organization and Business Operations | 3 Months Ended |
Mar. 31, 2023 | |
Description of Organization and Business Operations [Abstract] | |
Description of Organization and Business Operations | Note 1 – Description of Organization and Business Operations Global Partner Acquisition Corp II (the “Company”) was incorporated under the laws of the Cayman Islands as an exempted company on November 3, 2020. The Company was formed for the purpose of effecting a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, or the “Securities Act,” as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As of March 31, 2023, the Company had not commenced any operations. All activity for the period from November 3, 2020 (inception) to March 31, 2023 relates to the Company’s formation and the initial public offering (“Public Offering”) described below and, subsequent to the Public Offering, identifying and completing a suitable Business Combination. The Company will not generate any operating revenues until after completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Public Offering. In January 2023, the shareholders of the Company took various actions and the Company entered into various agreements resulting in a change of control of the Company, redemption of approximately 87% of its Class A ordinary shares, an extension of the date to complete a Business Combination and certain additional financing and other matters as discussed in further detail in the Form 10-K Annual Report filed on March 31, 2023, and the Form 8-K filed on January 18, 2023, with the Securities and Exchange Commission (“SEC”) as well as throughout these notes to unaudited condensed financial statements. All dollar amounts are rounded to the nearest thousand dollars. Sponsor and Public Offering: The Company’s sponsor is Global Partner Sponsor II LLC, a Delaware limited liability company (the “Sponsor”). The Company intends to finance a Business Combination with unredeemed proceeds from the $300,000,000 Public Offering (see Note 3) and a $8,350,000 private placement (see Note 4). Upon the closing of the Public Offering and the private placement, $300,000,000 was deposited in a trust account (the “Trust Account”) at closing on January 14, 2021. In January 2023, the following material transactions, among others, changed the control over and resources of the Company, all as further discussed in these notes to condensed financial statements, as follows: 1. On January 11, 2023, the Company held an Extension Meeting of its shareholders in which the shareholders approved the proposal to amend the Company’s amended and restated memorandum and articles of association (the “Extension Amendment Proposal”) to extend the date required to complete a Business Combination (as described further in Business Combination below). In connection with the vote to approve the Extension Amendment Proposal the holders of 26,068,281 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.167 per share for an aggregate redemption amount of approximately $265,050,000 resulting in 3,931,719 Class A ordinary shares remaining. 2. On January 13, 2023, the Company, entered into an Investment Agreement (the “Investment Agreement”) with the Sponsor and Endurance Global Partner II, LLC, a Delaware limited liability company (the “Investor”), pursuant to which the Investor agreed to contribute to the Sponsor an aggregate amount in cash equal to up to $3,000,000 (the “Investment Contribution”), which amount will be loaned to the Company in accordance with the Promissory Note (as defined below) (the “Investment Loan”), in consideration for which, the Sponsor issued to the Investor interests in certain equity securities of the Company. 3. Pursuant to the Investment Agreement, the Sponsor transferred control of the Sponsor to affiliates of Antarctica Capital Partners LLC. 4. Pursuant to the Investment Agreement, the Sponsor has agreed to lend to the Company the funds required to pay expenses incurred by the Company and reasonably related to the costs and expenses of facilitating the extension of the term of the Company. 5. Further, on January 13, 2023, Paul J. Zepf, Pano Anthos, Andrew Cook, James McCann and Jay Ripley tendered their resignations as directors of the Company. Additionally, Paul J. Zepf and David Apseloff resigned as officers of the Company. There was no known disagreement with any of the outgoing directors or officers on any matter relating to the Company’s operations, policies or practices. 6. The Company made settlements and received releases from several creditors in exchange for cash payments made resulting in the reduction of approximately $2,961,000 of accrued liabilities which are reflected as a credit to operating expenses in the accompanying Condensed Statements of Operations. Trust account – The funds in the Trust Account can only be invested in U.S. government treasury bills with a maturity of one hundred and eighty-five (185) days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940. On January 11, 2023, we liquidated the U.S. government treasury obligations or money market fund held in the trust account. Funds will remain in the Trust Account until the earlier of (i) the consummation of its initial Business Combination or (ii) the distribution of the Trust Account as described below. The remaining funds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective acquisition targets, legal and accounting fees related to regulatory reporting obligations, payment for services of investment professionals and support services, continued listing fees and continuing general and administrative expenses. The Company’s amended and restated memorandum and articles of association provided that, other than the withdrawal of interest to pay tax obligations, if any, less up to $100,000 of interest to pay dissolution expenses, none of the funds held in trust will be released until the earliest of (a) the completion of the initial Business Combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated memorandum of association (i) to modify the substance or timing of the Company’s obligation to redeem 100% of the public shares if the Company does not complete the initial Business Combination by the date by which the Company is required to consummate a business combination pursuant to the amended and restated memorandum and articles of association, January 14, 2024 if extended per below (previously January 14, 2023) (the “Termination Date”), or (ii) with respect to any other provision relating to shareholders’ rights or pre-Business Combination activity, and (c) the redemption of the public shares if the Company is unable to complete the initial Business Combination by the Termination Date, subject to applicable law, which includes the extended time that the Company has to consummate a Business Combination beyond the Termination Date as a result of a shareholder vote to amend the Company’s amended and restated articles of incorporation. The proceeds deposited in the Trust Account could become subject to the claims of creditors, if any, which could have priority over the claims of the Company’s public shareholders. On January 11, 2023, the Company’s shareholders voted to extend the date by which the Company has to consummate a business combination from January 14, 2023 (the “Original Termination Date”) to April 23, 2023 (the “Articles Extension Date”) and to allow the Company, without another shareholder vote, to elect to extend the date to consummate a business combination on a monthly basis for up to nine times by an additional one month each time up until the Termination Date of January 14, 2024. Upon each of the nine one-month extensions, the Sponsor or one or more of its affiliates, members or third-party designees may contribute to the Company $150,000 as a loan to be deposited into the Trust Account. Subsequent to March 31, 2023, in April and May 2023, the board of directors of the Company approved (i) two, one-month extensions of the Termination Date, resulting in a new Termination Date of June 12, 2023, and (ii) draws of an aggregate of $300,000 pursuant to the Extension Promissory Note - related party (as defined below). Business Combination: The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” is one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (excluding the deferred underwriting commission and taxes payable on interest earned on the trust account) at the time of signing a definitive agreement in connection with the Company’s initial Business Combination. There is no assurance that the Company will be able to successfully effect a Business Combination. The Company, after signing a definitive agreement for a Business Combination, will either (i) seek shareholder approval of the Business Combination at a meeting called for such purpose in connection with which shareholders may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest earned on funds held in the Trust Account and not previously released to pay income taxes, or (ii) provide shareholders with the opportunity to have their shares redeemed by the Company by means of a tender offer (and thereby avoid the need for a shareholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to commencement of the tender offer, including interest earned on funds held in the Trust Account and not previously released to pay income taxes. The decision as to whether the Company will seek shareholder approval of the Business Combination or will allow shareholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek shareholder approval unless a vote is required by the rules of the Nasdaq Capital Market. If the Company seeks shareholder approval, it will complete its Business Combination only if a majority of the outstanding Class A and Class B ordinary shares voted are voted in favor of the Business Combination. However, in no event will the Company redeem its public shares in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of a Business Combination. In such case, the Company would not proceed with the redemption of its public shares and the related Business Combination, and instead may search for an alternate Business Combination. If the Company holds a shareholder vote or there is a tender offer for shares in connection with a Business Combination, a public shareholder will have the right to redeem its shares for an amount in cash equal to its pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest earned on funds held in the Trust Account and not previously released to pay income taxes. As a result, such Class A ordinary shares are recorded at redemption amount and classified as temporary equity upon the completion of the Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, “Distinguishing Liabilities from Equity.” The amount in the Trust Account is initially funded at $10.00 per public Class A ordinary share ($300,000,000 held in the Trust Account divided by 30,000,000 public shares), see however Note 3 regarding shareholder redemptions in January 2023. As further discussed below, the Company will have until the Termination Date, that was proposed to and approved by the Company’s shareholders in the form of an amendment to the Company’s amended and restated memorandum and articles of association (the “Combination Period”). If the Company does not complete a Business Combination within this period of time, it shall (i) cease all operations except for the purposes of winding up and (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public Class A ordinary shares for a per share pro rata portion of the Trust Account, including interest earned on funds held in the Trust Account and not previously released to pay income taxes (less up to $100,000 of such net interest to pay dissolution expenses) and as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining shareholders, as part of its plan of dissolution and liquidation. The initial shareholders have entered into letter agreements with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founders Shares; however, if the initial shareholders or any of the Company’s officers, directors or affiliates acquire Class A ordinary shares in or after the Public Offering, they will be entitled to a pro rata share of the Trust Account with respect to the Class A ordinary shares so acquired upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the price per Unit (as defined below in Note 3) in the Public Offering. |
Summary of Significant Accounti
Summary of Significant Accounting Policies | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Summary of Significant Accounting Policies | Note 2 – Summary of Significant Accounting Policies Basis of Presentation: The accompanying unaudited condensed interim financial statements of the Company are presented in U.S. dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. Interim results are not necessarily indicative of results for a full year or any future periods. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s audited financial statements included in the Company’s Annual Report on Form 10-K filed with the SEC on March 18, 2022. Mandatory Liquidation and Going Concern: At March 31, 2023, the Company has approximately $3,000 in cash and approximately $1,989,000 in working capital deficit. The Company has incurred significant costs and expects to continue to incur additional costs in pursuit of its Business Combination. Further, if the Company cannot complete a Business Combination within the Combination Period, it could be forced to wind up its operations and liquidate unless it receives an extension approval from its shareholders. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. In connection with its financial position and intention to complete a business combination, the Company has secured financing from its Sponsor. The Company’s plan to deal with these uncertainties is to use the financing from the Sponsor to complete a Business Combination prior to deadline as extended from time to time. There is no assurance that the Company’s plans to consummate a Business Combination will be successful or successful within the Combination Period. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Emerging Growth Company: Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. Net Income per Ordinary Share: Net income per ordinary share is computed by dividing net income applicable to ordinary shareholders by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of the warrants sold in the Public Offering and private placement to purchase an aggregate of 11,221,954 at March 31, 2023 (15,566,667 at December 31, 2022) Class A ordinary shares in the calculation of diluted income per ordinary share, since their inclusion would be anti-dilutive under the treasury stock method and are dependent on future events. As a result, diluted income per ordinary share is the same as basic income per ordinary share for the period. The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata among the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average number of ordinary shares outstanding during the respective period. The changes in redemption value that are accreted to Class A ordinary subject to redemption (see below) is representative of fair value and therefore is not factored into the calculation of earnings per share. The following table reflects the earnings per share after allocating income between the shares based on outstanding shares: Three months ended Three months ended March 31, 2023 March 31, 2022 Class A Class B Class A Class B Numerator: Basic and diluted net income per ordinary share: Allocation of income – basic and diluted $ 431,000 $ 451,000 $ 5,347,000 $ 1,336,000 Denominator: Basic and diluted weighted average ordinary shares: 7,118,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income per ordinary share $ 0.06 $ 0.06 $ 0.18 $ 0.18 Concentration of Credit Risk: The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash and Cash Equivalents: The Company considers all highly liquid instruments with original maturities of three months or less when acquired, to be cash equivalents. The Company had no cash equivalents at March 31, 2023 and December 31, 2022. Fair Value Measurements: The Company complies with FASB ASC 820, “Fair Value Measurements,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. As of March 31, 2023 and December 31, 2022, the carrying values of cash, prepaid expenses, accounts payable, accrued expenses and notes payable – related party approximate their fair values primarily due to the short-term nature of the instruments. Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Offering Costs: The Company complies with the requirements of the FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A— “Expenses of Offering.” Costs incurred in connection with preparation for the Public Offering totaled approximately $17,054,000 including $16,500,000 of underwriters’ discount. Such costs were allocated among the temporary equity and warrant liability components, based on their relative fair-value. Upon completion of the Public Offering approximately $16,254,000 has been charged to temporary equity for the temporary equity components and approximately $800,000 has been charged to other expense for the warrant liability. Class A Ordinary Shares Subject to Possible Redemption: As discussed in Note 3, all of the 30,000,000 Class A ordinary shares sold as part of the Units (as defined below) in the Public Offering contain a redemption feature that allows for the redemption under the Company’s liquidation or tender offer/shareholder approval provisions. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company had not specified a maximum redemption threshold, its articles of association provide that in no event will it redeem its public shares in an amount that would cause its net tangible assets (shareholders’ equity) to be less than $5,000,001. However, because all of the Class A ordinary shares are redeemable, all of the shares are recorded as Class A ordinary shares subject to redemption on the enclosed balance sheets. On January 11, 2023, in connection with the vote to approve the Extension Amendment Proposal the holders of 26,068,281 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.167 per share for an aggregate redemption amount of approximately $265,050,000 reducing the number of Class A ordinary shares to 3,931,719. The Company recognizes changes immediately as they occur and adjusts the carrying value of the securities at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A ordinary shares are affected by adjustments to additional paid-in capital. Accordingly, 3,931,719 and 30,000,000, respectively, were classified outside of permanent equity at March 31, 2023 and December 31, 2022 and 2021. Class A ordinary shares subject to redemption consist of the following: Gross proceeds of Public Offering $ 300,000,000 Less: Proceeds allocated to Public Warrants (14,100,000 ) Offering costs (16,254,000 ) Plus: Accretion of carrying value to redemption value 30,354,000 Subtotal at inception and at December 31, 2021 300,000,000 Accretion of carrying value to redemption value 4,675,000 Class A ordinary shares subject to possible redemption at December 31, 2022 $ 304,675,000 Class A ordinary shares redeemed on January 11, 2023 (265,050,000 ) Accretion of carrying value to redemption value 1,371,000 40,996,000 Income Taxes: FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the balance sheet recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company recognizes interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at March 31, 2023 or December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. The Company is considered a Cayman Islands exempted company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Extension Promissory Notes - Related Party: The Company has elected the fair value option to account for its Extension Promissory Notes - related party with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of working capital loan-related party on the statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability. Warrant Liability: The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as a liability at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statement of operations. Costs associated with issuing the warrants accounted for as liabilities are charged to operations when the warrants are issued. Recent Accounting Pronouncements: In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, “Debt — Debt with Conversion and Other Options” (Subtopic 470-20) and “Derivatives and Hedging — Contracts in Entity’s Own Equity” (Subtopic 815-40) (“ASU 2020-06”), to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis. The Company has adopted this standard for its Extension Promissory Notes - related party as further discussed in Note 4. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. |
Public Offering
Public Offering | 3 Months Ended |
Mar. 31, 2023 | |
Public Offering [Abstract] | |
Public Offering | Note 3 – Public Offering On January 14, 2021, the Company consummated the Public Offering and sale of 30,000,000 units at a price of $10.00 per unit (the “Units”). Each Unit consists of one share of the Company’s Class A ordinary shares, $0.0001 par value, one-sixth of one detachable redeemable warrant (the “Detachable Redeemable Warrants”) and the contingent right to receive, in certain circumstances, in connection with the Business Combination, one-sixth of one distributable redeemable warrant for each public share that a public shareholder holds and does not redeem in connection with the Company’s initial Business Combination (the “Distributable Redeemable Warrants,” and together with the Detachable Redeemable Warrants, the “Redeemable Warrants”). Each whole Redeemable Warrant offered in the Public Offering is exercisable to purchase one of the Company’s Class A ordinary shares. Only whole Redeemable Warrants may be exercised. Under the terms of the warrant agreement, the Company has agreed to use its commercially reasonable efforts to file a new registration statement under the Securities Act, following the completion of the Company’s initial Business Combination covering the Class A ordinary shares issuable upon the exercise of warrants. No fractional shares will be issued upon exercise of the Redeemable Warrants. If, upon exercise of the Redeemable Warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the Redeemable Warrant holder. Each Redeemable Warrant will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Public Offering and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination on or prior to the end of the Combination Period. the Redeemable Warrants will expire at the end of such period. If the Company is unable to deliver registered Class A ordinary shares to the holder upon exercise of a Redeemable Warrant during the exercise period, there will be no net cash settlement of these Redeemable Warrants and the Redeemable Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the Redeemable Warrants become exercisable, the Company may redeem the outstanding Redeemable Warrants in whole and not in part at a price of $0.01 per Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within the 30- trading day period ending on the third trading day before the Company sends the notice of redemption to the Redeemable Warrant holders, and that certain other conditions are met. Once the Redeemable Warrants become exercisable, the Company may also redeem the outstanding Redeemable Warrants in whole and not in part at a price of $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the closing price of the Class A ordinary shares equals or exceeds $10.00 per share on the trading day prior to the date on which the Company sends the notice of redemption, and that certain other conditions are met. If the closing price of the Class A ordinary shares is less than $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders, the Private Placement Warrants must also concurrently be called for redemption on the same terms as the outstanding Public Warrants, as described above. If issued, the Distributable Redeemable Warrants are identical to the Redeemable Warrants and together represent the Public Warrants. The Company had granted the underwriters a 45-day option to purchase up to 2,500,000 Units to cover any over- allotments, at the Public Offering price less the underwriting discounts and commissions and such option was exercised in full at the closing of the Public Offering and included in the 30,000,000 Units sold on January 14, 2021. The Company paid an underwriting discount of 2.0% of the per Unit price, $6,000,000, to the underwriters at the closing of the Public Offering and there is a deferred underwriting fee of 3.5% of the per Unit price, $10,500,000, which is payable upon the completion of the Company’s initial Business Combination. The shareholders of the Company approved the Extension Amendment Proposal (as defined below) at the extraordinary general meeting (the “Extension Meeting”) and on January 11, 2023, in connection with that vote, the holders of 26,068,281 Class A ordinary shares of the Company properly exercised their right to redeem their shares for an aggregate price of approximately $10.167 per share, for an aggregate redemption amount of approximately $265,050,166. In addition, 4,344,714 contingent redeemable warrants will no longer be available to the former holders of the 26,068,281 Class A ordinary shares redeemed and so the carrying amount of those warrants, approximately $130,000, was removed from the warrant liabilities on the unaudited condensed balance sheet. |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Note 4 – Related Party Transactions Founder Shares: During 2020, the Sponsor purchased 7,187,500 Class B ordinary shares (the “Founder Shares”) for $25,000 (which amount was paid directly for organizational costs and costs of the Public Offering by the Sponsor on behalf of the Company), or approximately $0.003 per share. In January 2021, the Company effected a share capitalization resulting in there being an aggregate of 7,500,000 Founder Shares issued. The Founder Shares are substantially identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares automatically convert into Class A ordinary shares at the time of the initial Business Combination, or at any time prior thereto at the option of the holder, and are subject to certain transfer restrictions, as described in more detail below, and the Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement) exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. The Sponsor agreed to forfeit up to 625,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters. The underwriters’ exercised their over-allotment option in full and therefore such shares are no longer subject to forfeiture. In addition to the vesting provisions of the Founder Shares discussed in Note 7, the Company’s initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares until the earlier of (A) one year after the completion of the Company’s initial Business Combination, or (B), subsequent to the Company’s initial Business Combination, if (x) the last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share splits, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Warrants: The Sponsor purchased from the Company an aggregate of 5,566,667 warrants at a price of $1.50 per warrant (a purchase price of $8,350,000) in a private placement that occurred simultaneously with the completion of the Public Offering (the “Private Placement Warrants”). Each Private Placement Warrant entitles the holder to purchase one Class A ordinary share at $11.50 per share. The purchase price of the Private Placement Warrants was added to the proceeds from the Public Offering, net of expenses of the offering and working capital to be available to the Company, to be held in the Trust Account pending completion of the Company’s initial Business Combination. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination and they will be non-redeemable so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being sold in the Public Offering. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the Redeemable Warrants being sold as part of the Units in the Public Offering and have no net cash settlement provisions. If the Company does not complete a Business Combination, then the proceeds from the sale of the Private Placement Warrants will be part of the liquidating distribution from the Trust Account to the public shareholders and the Private Placement Warrants issued to the Sponsor will expire worthless. Registration Rights: The Company’s initial shareholders and the holders of the Private Placement Warrants are entitled to registration rights pursuant to a registration and shareholder rights agreement. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders will have piggyback registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements. There will be no penalties associated with delays in registering the securities under the registration and shareholder rights agreement. Related Party Loans: Sponsor loans Sponsor working capital loans On January 13, 2023, the Company and the Sponsor agreed to extend the date of maturity of the Note to the earlier of (i) the Termination Date, (ii) the consummation of a business combination of the Company and (iii) the liquidation of the Company. On January 3, 2023, the Company issued a promissory note (the “January 3, 2023 Note”) in the principal amount of up to $250,000 to its Sponsor. The January 3, 2023 Note was issued in connection with advances the Sponsor may make to the Company for expenses reasonably related to its business and the consummation of the Business Combination. The January 3, 2023 Note bears no interest and is due and payable upon the Business Combination. As of March 31, 2023, no amounts have been drawn down and there was no outstanding principal balance under the note. At the election of the Payee, $250,000 of the unpaid principal amount of the January 3, 2023 Note may be converted into warrants of the Company (“Warrants”), at a price of $1.50 per warrant, each warrant exercisable for one Class A ordinary share, $0.0001 par value per share, of the Company. The Warrants shall be identical to the Private Placement Warrants issued to the Sponsor at the time of the Company’s initial public offering. On January 13, 2023, the Company issued a promissory note (the “January 13, 2023 Note” and together with the January 3, 2023 Note, the “Extension Promissory Notes – related party”) in the principal amount of up to $3,000,000 to its Sponsor. The January 13, 2023 Note was issued in connection with advances the Sponsor may make to the Company for contributions to the Trust Account in connection with the Extension and other expenses reasonably related to its business and the consummation of the Business Combination. The January 13, 2023 Note bears no interest and is due and payable upon the Business Combination. At the election of the Payee, all or a portion of the unpaid principal amount of the Note may be converted into Warrants, at a price of $1.50 per warrant, each warrant exercisable for one Class A ordinary share, $0.0001 par value per share, of the Company. The Warrants shall be identical to the Private Placement Warrants issued to the Sponsor at the time of the Company’s initial public offering. During the three months ended March 31, 2023, the Company made four drawdowns under the January 13, 2023 Note in order to pay extension payments and for working capital. The Company adopted the fair value option with respect to these notes. At each draw and at March 31, 2023, the company had an independent valuation firm value the notes. The valuation firm uses a Monte Carlo method to value the notes. Those valuations showed that the fair value of the notes (approximately $572,000) was materially less than the drawdown (approximately 377,000 less). Such amount at inception, $377,000, was credited to equity. The aggregate principal balance outstanding was then revalued to fair value at March 31, 2023 resulting in an increase to the fair value of approximately $32,000 and is stated in the balance stated at March 31, 2023 at fair value of $604,000, approximately $345,000 less than the outstanding principal balance under the note of approximately $949,000. The following table presents information about the Company’s Extension Promissory Notes – related party that are measured at fair value on a recurring basis as of March 31, 2023 and indicates the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value. Fair Value Measured as of March 31, 2023 Level 1 Level 2 Level 3 Total Extension Promissory Notes - related party - - 604,000 604,000 Total fair value $ - $ - $ 604,000 $ 604,000 The following table provides quantitative information regarding the Level 3 fair value measurements inputs at their measurement dates: Exercise price $ 1.50 Unobserved Deal-Scenario Stock price $ 3.63 Option term (in years) 5 years Volatility 3 % Implied Probability of Merger Success 60 % Subsequent to March 31, 2023, in April and May 2023, the Company borrowed an aggregate $300,000 to fund the monthly extension payments for those two months. In addition, the Company borrowed an additional approximately $20,000 subsequent to March 31, 2023 to fund working capital needs. Administrative Services Agreement: The Company has agreed to pay $25,000 a month to the Sponsor for office space and rent and for the services to be provided by one or more investment professionals, creation and maintenance of the Company’s website, and miscellaneous additional services. Services commenced on the date the securities are first listed on the Nasdaq Capital Market and will terminate upon the earlier of the consummation by the Company of an initial Business Combination or the liquidation of the Company. Approximately $75,000 and $75,000 were charged to general and administrative expenses during the three months ended March 31, 2023 and 2022 for this agreement. There was approximately $50,000 and $-0- included in accrued liabilities at March 31, 2023 and December 31, 2022, respectively. |
Accounting for Warrant Liabilit
Accounting for Warrant Liability | 3 Months Ended |
Mar. 31, 2023 | |
Accounting for Warrant Liability [Abstract] | |
Accounting for Warrant Liability | Note 5 – Accounting for Warrant Liability At March 31, 2023 and December 31, 2022, there were 15,566,667 and 11,221,954 warrants, respectively, outstanding including 5,655,286 Public Warrants and 5,566,667 Private Placement Warrants outstanding at March 31, 2023 and 10,000,000 Public Warrants and 5,566,667 Private Placement Warrants outstanding at December 31, 2022. 4,344,714 contingent redeemable warrants that would have been exercisable by the former holders of the 26,068,281 Class A ordinary shares are no longer available for exercise. The Company’s warrants are not indexed to the Company’s ordinary shares in the manner contemplated by ASC Section 815-40-15 because the holder of the instrument is not an input into the pricing of a fixed-for-fixed option on equity shares. As such, the company’s warrants are accounted for as warrant liabilities which are required to be valued at fair value at each reporting period. The following tables present information about the Company’s warrant liabilities that are measured at fair value on a recurring basis at March 31, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Description At Quoted Prices Significant Significant Warrant Liabilities: Public Warrants $ 1,188,000 $ 1,188,000 $ - $ - Private Placement Warrants 1,169,000 - 1,169,000 - Warrant liability at December 31, 2021 $ 2,357,000 $ 1,188,000 $ 1,169,000 $ - Description At Quoted Prices Significant Significant Warrant Liabilities: Public Warrants $ 300,000 $ 300,000 $ - $ - Private Placement Warrants 167,000 - 167,000 - Warrant liability at March 31, 2023 $ 467,000 $ 300,000 $ 167,000 $ - At March 31, 2023 and December 31, 2022, the Company values its (a) Public Warrants based on the closing price at March 31, 2023 and December 31, 2022, respectively, in an active market and (b) Private Placement Warrants based on the closing price of the Public Warrants since they are similar instruments. The warrant liabilities are not subject to qualified hedge accounting. The Company’s policy is to record transfers at the end of the reporting period. There were no transfers during the three months ended March 31, 2023 or the year ended December 31, 2022. |
Trust Account and Fair Value Me
Trust Account and Fair Value Measurement | 3 Months Ended |
Mar. 31, 2023 | |
Trust Account and Fair Value Measurement [Abstract] | |
Trust Account and Fair Value Measurement | Note 6 – Trust Account and Fair Value Measurement The Company complies with FASB ASC 820, “Fair Value Measurements,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. Upon the closing of the Public Offering and the private placement, a total of $300,000,000 was deposited into the Trust Account. On January 11, 2023, shareholders redeemed 26,068,281 Class A ordinary shares at $10.167 per share, approximately $265,050,000, from the Trust Account and from Class A ordinary shares subject to redemption as further discussed in these notes to condensed financial statements. The Company classifies its U.S. government treasury bills and equivalent securities (when it owns them) as held to maturity in accordance with FASB ASC 320, “Investments – Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Money market funds are valued at market. The funds in the Trust Account were held in an interest bearing cash account at March 31, 2023. The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2022 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Since all of the Company’s permitted investments at December 31, 2022 consisted of money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assts or liabilities as follows: Carrying Quoted Description December 31, Markets Assets: Money Market Fund $ 304,675,000 $ 304,675,000 Total $ 304,675,000 $ 304,675,000 |
Shareholders_ Deficit
Shareholders’ Deficit | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Shareholders’ Deficit | Note 7 – Shareholders’ Deficit Ordinary Shares: The authorized ordinary shares of the Company include 500,000,000 Class A ordinary shares, par value, $0.0001, and 50,000,000 Class B ordinary shares, par value, $0.0001, or 550,000,000 ordinary shares in total. The Company may (depending on the terms of the Business Combination) be required to increase the authorized number of shares at the same time as its shareholders vote on the Business Combination to the extent the Company seeks shareholder approval in connection with its Business Combination. Except with respect to matters pertaining to directors prior to the Business Combination, holders of the Company’s Class A and Class B ordinary shares vote together as a single class and are entitled to one vote for each Class A and Class B ordinary share. The Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. At March 31, 2023 and December 31, 2022, there were 7,500,000 Class B ordinary shares issued and outstanding, and -0- and -0- Class A ordinary shares issued and outstanding (after deducting 3,931,719 and 30,000,000, respectively, Class A ordinary shares subject to possible redemption at March 31, 2023 and December 31, 2023). Preference Shares: The Company is authorized to issue 5,000,000 preference shares, par value $0.0001, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2023 and December 31, 2022, there were no |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies [Abstract] | |
Commitments and Contingencies | Note 8 – Commitments and Contingencies Business Combination Costs: In connection with identifying an initial Business Combination candidate and negotiating an initial Business Combination, the Company has entered into, and may enter into additional, engagement letters or agreements with various consultants, advisors, professionals and others. The services under these engagement letters and agreements are material in amount and in some instances include contingent or success fees. Contingent or success fees (but not deferred underwriting commission) would be charged to operations in the quarter that an initial Business Combination is consummated. In most instances (except with respect to the Company’s independent registered public accounting firm), these engagement letters and agreements are expected to specifically provide that such counterparties waive their rights to seek repayment from the funds in the Trust Account. Risks and Uncertainties: COVID-19 — Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the pandemic could have an effect on the Company’s financial position, results of operations and/or search for a target company and/or a target company’s unaudited condensed financial position and results of its operations, the specific impact is not readily determinable as of the date of these financial statements. These unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. Bank Closures — Management acknowledges that the Company depends on a variety of U.S. and multi-national financial institutions for banking services. Market conditions can impact the viability of these institutions, which in effect will affect the Company’s ability to maintain and provide assurances that it can access its cash and cash equivalents in a timely manner or at all. Any inability to access or delay in accessing these funds could adversely affect the Company’s liquidity, business and financial condition. Conflict in Ukraine — In February 2022, the Russian Federation and Belarus commenced a military action against the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The impact of this action and related sanctions on the world economy is not determinable as of the date of these unaudited condensed financial statements. Certain repurchases of stock (including redemptions) by publicly traded domestic corporations - On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations, among others. The excise tax is imposed on the repurchasing corporation itself, not its stockholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The IR Act applies to repurchases that occur after December 31, 2022. Whether and to what extent the Company would be subject to the excise tax in connection with a business combination, liquidation or partial redemption would depend on a number of factors. |
Accounting Policies, by Policy
Accounting Policies, by Policy (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation: The accompanying unaudited condensed interim financial statements of the Company are presented in U.S. dollars and in conformity with accounting principles generally accepted in the United States of America (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the financial position and the results of operations and cash flows for the periods presented. Certain information and disclosures normally included in financial statements prepared in accordance with GAAP have been omitted pursuant to such rules and regulations. Interim results are not necessarily indicative of results for a full year or any future periods. The accompanying unaudited condensed interim financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Company’s audited financial statements included in the Company’s Annual Report on Form 10-K filed with the SEC on March 18, 2022. |
Mandatory Liquidation and Going Concern | Mandatory Liquidation and Going Concern: At March 31, 2023, the Company has approximately $3,000 in cash and approximately $1,989,000 in working capital deficit. The Company has incurred significant costs and expects to continue to incur additional costs in pursuit of its Business Combination. Further, if the Company cannot complete a Business Combination within the Combination Period, it could be forced to wind up its operations and liquidate unless it receives an extension approval from its shareholders. These conditions raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the date that the financial statements are issued. In connection with its financial position and intention to complete a business combination, the Company has secured financing from its Sponsor. The Company’s plan to deal with these uncertainties is to use the financing from the Sponsor to complete a Business Combination prior to deadline as extended from time to time. There is no assurance that the Company’s plans to consummate a Business Combination will be successful or successful within the Combination Period. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. |
Emerging Growth Company | Emerging Growth Company: Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when an accounting standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. |
Net Income per Ordinary Share | Net Income per Ordinary Share: Net income per ordinary share is computed by dividing net income applicable to ordinary shareholders by the weighted average number of ordinary shares outstanding for the period. The Company has not considered the effect of the warrants sold in the Public Offering and private placement to purchase an aggregate of 11,221,954 at March 31, 2023 (15,566,667 at December 31, 2022) Class A ordinary shares in the calculation of diluted income per ordinary share, since their inclusion would be anti-dilutive under the treasury stock method and are dependent on future events. As a result, diluted income per ordinary share is the same as basic income per ordinary share for the period. The Company complies with the accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata among the two classes of shares. Net income per ordinary share is calculated by dividing the net income by the weighted average number of ordinary shares outstanding during the respective period. The changes in redemption value that are accreted to Class A ordinary subject to redemption (see below) is representative of fair value and therefore is not factored into the calculation of earnings per share. The following table reflects the earnings per share after allocating income between the shares based on outstanding shares: Three months ended Three months ended March 31, 2023 March 31, 2022 Class A Class B Class A Class B Numerator: Basic and diluted net income per ordinary share: Allocation of income – basic and diluted $ 431,000 $ 451,000 $ 5,347,000 $ 1,336,000 Denominator: Basic and diluted weighted average ordinary shares: 7,118,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income per ordinary share $ 0.06 $ 0.06 $ 0.18 $ 0.18 |
Concentration of Credit Risk | Concentration of Credit Risk: The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. |
Cash and Cash Equivalents | Cash and Cash Equivalents: The Company considers all highly liquid instruments with original maturities of three months or less when acquired, to be cash equivalents. The Company had no cash equivalents at March 31, 2023 and December 31, 2022. |
Fair Value Measurements | Fair Value Measurements: The Company complies with FASB ASC 820, “Fair Value Measurements,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. As of March 31, 2023 and December 31, 2022, the carrying values of cash, prepaid expenses, accounts payable, accrued expenses and notes payable – related party approximate their fair values primarily due to the short-term nature of the instruments. Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. |
Use of Estimates | Use of Estimates: The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the balance sheet and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant estimates included in these financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. |
Offering Costs | Offering Costs: The Company complies with the requirements of the FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A— “Expenses of Offering.” Costs incurred in connection with preparation for the Public Offering totaled approximately $17,054,000 including $16,500,000 of underwriters’ discount. Such costs were allocated among the temporary equity and warrant liability components, based on their relative fair-value. Upon completion of the Public Offering approximately $16,254,000 has been charged to temporary equity for the temporary equity components and approximately $800,000 has been charged to other expense for the warrant liability. |
Class A Ordinary Shares Subject to Possible Redemption | Class A Ordinary Shares Subject to Possible Redemption: As discussed in Note 3, all of the 30,000,000 Class A ordinary shares sold as part of the Units (as defined below) in the Public Offering contain a redemption feature that allows for the redemption under the Company’s liquidation or tender offer/shareholder approval provisions. In accordance with FASB ASC 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company had not specified a maximum redemption threshold, its articles of association provide that in no event will it redeem its public shares in an amount that would cause its net tangible assets (shareholders’ equity) to be less than $5,000,001. However, because all of the Class A ordinary shares are redeemable, all of the shares are recorded as Class A ordinary shares subject to redemption on the enclosed balance sheets. On January 11, 2023, in connection with the vote to approve the Extension Amendment Proposal the holders of 26,068,281 Class A ordinary shares of the Company exercised their right to redeem their shares for cash at a redemption price of approximately $10.167 per share for an aggregate redemption amount of approximately $265,050,000 reducing the number of Class A ordinary shares to 3,931,719. The Company recognizes changes immediately as they occur and adjusts the carrying value of the securities at the end of each reporting period. Increases or decreases in the carrying amount of redeemable Class A ordinary shares are affected by adjustments to additional paid-in capital. Accordingly, 3,931,719 and 30,000,000, respectively, were classified outside of permanent equity at March 31, 2023 and December 31, 2022 and 2021. Class A ordinary shares subject to redemption consist of the following: Gross proceeds of Public Offering $ 300,000,000 Less: Proceeds allocated to Public Warrants (14,100,000 ) Offering costs (16,254,000 ) Plus: Accretion of carrying value to redemption value 30,354,000 Subtotal at inception and at December 31, 2021 300,000,000 Accretion of carrying value to redemption value 4,675,000 Class A ordinary shares subject to possible redemption at December 31, 2022 $ 304,675,000 Class A ordinary shares redeemed on January 11, 2023 (265,050,000 ) Accretion of carrying value to redemption value 1,371,000 40,996,000 |
Income Taxes | Income Taxes: FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the balance sheet recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company recognizes interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at March 31, 2023 or December 31, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has been subject to income tax examinations by major taxing authorities since inception. The Company is considered a Cayman Islands exempted company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the periods presented. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. |
Extension Promissory Notes - Related Party | Extension Promissory Notes - Related Party: The Company has elected the fair value option to account for its Extension Promissory Notes - related party with its Sponsor as defined and more fully described in Note 4. As a result of applying the fair value option, the Company records each draw at fair value with a gain or loss recognized at issuance, and subsequent changes in fair value are recorded as change in the fair value of working capital loan-related party on the statements of operations. The fair value is based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumption about the assumptions a market participant would use in pricing the asset or liability. |
Warrant Liability | Warrant Liability: The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, “Distinguishing Liabilities from Equity” (“ASC 480”), and ASC 815, “Derivatives and Hedging” (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding. For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as a liability at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statement of operations. Costs associated with issuing the warrants accounted for as liabilities are charged to operations when the warrants are issued. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements: In August 2020, the FASB issued Accounting Standards Update (“ASU”) 2020-06, “Debt — Debt with Conversion and Other Options” (Subtopic 470-20) and “Derivatives and Hedging — Contracts in Entity’s Own Equity” (Subtopic 815-40) (“ASU 2020-06”), to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective January 1, 2024 and should be applied on a full or modified retrospective basis. The Company has adopted this standard for its Extension Promissory Notes - related party as further discussed in Note 4. Management does not believe that any other recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. |
Summary of Significant Accoun_2
Summary of Significant Accounting Policies (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting Policies [Abstract] | |
Schedule of earnings per share | Three months ended Three months ended March 31, 2023 March 31, 2022 Class A Class B Class A Class B Numerator: Basic and diluted net income per ordinary share: Allocation of income – basic and diluted $ 431,000 $ 451,000 $ 5,347,000 $ 1,336,000 Denominator: Basic and diluted weighted average ordinary shares: 7,118,000 7,500,000 30,000,000 7,500,000 Basic and diluted net income per ordinary share $ 0.06 $ 0.06 $ 0.18 $ 0.18 |
Schedule of ordinary shares subject to redemption consist | Gross proceeds of Public Offering $ 300,000,000 Less: Proceeds allocated to Public Warrants (14,100,000 ) Offering costs (16,254,000 ) Plus: Accretion of carrying value to redemption value 30,354,000 Subtotal at inception and at December 31, 2021 300,000,000 Accretion of carrying value to redemption value 4,675,000 Class A ordinary shares subject to possible redemption at December 31, 2022 $ 304,675,000 Class A ordinary shares redeemed on January 11, 2023 (265,050,000 ) Accretion of carrying value to redemption value 1,371,000 40,996,000 |
Related Party Transactions (Tab
Related Party Transactions (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Schedule of of level 3 fair value measurements inputs at their measurement dates | Fair Value Measured as of March 31, 2023 Level 1 Level 2 Level 3 Total Extension Promissory Notes - related party - - 604,000 604,000 Total fair value $ - $ - $ 604,000 $ 604,000 |
Schedule of the following table provides quantitative information regarding the Level 3 fair value measurements | Exercise price $ 1.50 Unobserved Deal-Scenario Stock price $ 3.63 Option term (in years) 5 years Volatility 3 % Implied Probability of Merger Success 60 % |
Accounting for Warrant Liabil_2
Accounting for Warrant Liability (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Accounting for Warrant Liability [Abstract] | |
Schedule of warrant liabilities that are measured at fair value on a recurring basis | Description At Quoted Prices Significant Significant Warrant Liabilities: Public Warrants $ 1,188,000 $ 1,188,000 $ - $ - Private Placement Warrants 1,169,000 - 1,169,000 - Warrant liability at December 31, 2021 $ 2,357,000 $ 1,188,000 $ 1,169,000 $ - Description At Quoted Prices Significant Significant Warrant Liabilities: Public Warrants $ 300,000 $ 300,000 $ - $ - Private Placement Warrants 167,000 - 167,000 - Warrant liability at March 31, 2023 $ 467,000 $ 300,000 $ 167,000 $ - |
Trust Account and Fair Value _2
Trust Account and Fair Value Measurement (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Trust Account and Fair Value Measurement [Abstract] | |
Schedule of fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets or liabilities | Carrying Quoted Description December 31, Markets Assets: Money Market Fund $ 304,675,000 $ 304,675,000 Total $ 304,675,000 $ 304,675,000 |
Description of Organization a_2
Description of Organization and Business Operations (Details) - USD ($) | 1 Months Ended | 3 Months Ended | |||
Jan. 11, 2023 | Jan. 31, 2023 | Mar. 31, 2023 | Jan. 13, 2023 | Jan. 14, 2021 | |
Description of Organization and Business Operations [Line items] | |||||
Shares redemption percentage | 87% | 100% | |||
Proceeds from public offering | $ 300,000,000 | ||||
Trust account | $ 300,000,000 | ||||
Redemption price per share (in Dollars per share) | $ 10.167 | ||||
Redemption amount | $ 265,050,000 | ||||
Cash | $ 3,000,000 | ||||
Accrued liabilities | 2,961,000 | ||||
Interest dissolution expenses | 100,000 | ||||
Loan deposited | 150,000 | ||||
Aggregate amount | $ 300,000 | ||||
Taxes payable on interest earned percentage | 80% | ||||
Net tangible assets | $ 5,000,001 | ||||
Price per share (in Dollars per share) | $ 10 | ||||
Amount held in trust account | $ 300,000,000 | ||||
Shares held in trust account (in Shares) | 30,000,000 | ||||
Dissolution expenses | $ 100,000 | ||||
Private Placement [Member] | |||||
Description of Organization and Business Operations [Line items] | |||||
Proceeds from private placement | $ 8,350,000 | ||||
Class A Ordinary Shares [Member] | |||||
Description of Organization and Business Operations [Line items] | |||||
Extension amendment proposal the holders shares (in Shares) | 26,068,281 | ||||
Remaining redemption shares (in Shares) | 3,931,719 |
Summary of Significant Accoun_3
Summary of Significant Accounting Policies (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Jan. 11, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Summary of Significant Accounting Policies (Details) [Line Items] | ||||
Cash | $ 3,000 | |||
Negative working capital | $ 1,989,000 | |||
Aggregate purchase shares (in Shares) | 11,221,954 | 15,566,667 | ||
Federal depository insurance coverage | $ 250,000 | |||
Total offering cost | 17,054,000 | |||
Underwriters' discount | 16,500,000 | |||
Charged to temporary equity | 16,254,000 | |||
Other expenses | 800,000 | |||
Net tangible asset | $ 5,000,001 | |||
Ordinary shares price (in Dollars per share) | $ 3.63 | |||
Redemption amount | $ 304,675,000 | |||
Permanent equity shares (in Shares) | 3,931,719 | 30,000,000 | 30,000,000 | |
Class A Ordinary Shares [Member] | ||||
Summary of Significant Accounting Policies (Details) [Line Items] | ||||
Number of units issued in transaction (in Shares) | 30,000,000 | |||
Redeemed shares (in Shares) | 26,068,281 | |||
Ordinary shares price (in Dollars per share) | $ 10.167 | |||
Redemption amount | $ 265,050,000 | |||
Shares reducing (in Shares) | 3,931,719 |
Summary of Significant Accoun_4
Summary of Significant Accounting Policies (Details) - Schedule of earnings per share - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Class A [Member] | ||
Basic and diluted net income per ordinary share: | ||
Allocation of income – basic | $ 431,000 | $ 5,347,000 |
Denominator: | ||
Basic weighted average ordinary shares: | 7,118,000 | 30,000,000 |
Basic net income per ordinary share | $ 0.06 | $ 0.18 |
Class B [Member] | ||
Basic and diluted net income per ordinary share: | ||
Allocation of income – basic | $ 451,000 | $ 1,336,000 |
Denominator: | ||
Basic weighted average ordinary shares: | 7,500,000 | 7,500,000 |
Basic net income per ordinary share | $ 0.06 | $ 0.18 |
Summary of Significant Accoun_5
Summary of Significant Accounting Policies (Details) - Schedule of earnings per share (Parentheticals) - USD ($) | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Class A [Member] | ||
Schedule of Earnings Per Share [Abstract] | ||
Allocation of income – diluted | $ 446,000 | $ 5,347,000 |
Diluted weighted average ordinary shares | 3,560,000 | 30,000,000 |
Diluted net income per ordinary share | $ 0.06 | $ 0.18 |
Class B [Member] | ||
Schedule of Earnings Per Share [Abstract] | ||
Allocation of income – diluted | $ 848,000 | $ 1,336,000 |
Diluted weighted average ordinary shares | 7,500,000 | 7,500,000 |
Diluted net income per ordinary share | $ 0.06 | $ 0.18 |
Summary of Significant Accoun_6
Summary of Significant Accounting Policies (Details) - Schedule of ordinary shares subject to redemption consist - USD ($) | 3 Months Ended | 12 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Schedule of Ordinary Shares Subject To Redemption Consist [Abstract] | |||
Gross proceeds of Public Offering | $ 300,000,000 | ||
Less: Proceeds allocated to Public Warrants | (14,100,000) | ||
Offering costs | (16,254,000) | ||
Accretion of carrying value to redemption value | $ 1,371,000 | $ 4,675,000 | 30,354,000 |
Total | 40,996,000 | ||
Subtotal at inception and at December 31, 2021 | $ 300,000,000 | ||
Class A ordinary shares subject to possible redemption at December 31, 2022 | $ 304,675,000 | ||
Class A ordinary shares redeemed on January 11, 2023 | $ (265,050,000) |
Public Offering (Details)
Public Offering (Details) - USD ($) | 3 Months Ended | |||
Jan. 11, 2023 | Jan. 14, 2021 | Mar. 31, 2023 | Dec. 31, 2022 | |
Public Offering (Details) [Line Items] | ||||
Number of units sold (in Shares) | 30,000,000 | |||
Price per unit | $ 10 | |||
Public offering expire | 5 years | |||
Redeemable warrants | $ 0.01 | |||
Ordinary shares equals exceeds | $ 18 | |||
Underwriting discount percentage | 2% | |||
Underwriting unit price (in Dollars) | $ 6,000,000 | |||
Deferred underwriting percentage | 3.50% | |||
Deferred underwriting fees payable (in Dollars) | $ 10,500,000 | |||
Redemption price per share | $ 10.167 | |||
Redeemed value (in Dollars) | $ 265,050,166 | |||
Contingent redeemable warrants (in Shares) | 4,344,714 | |||
Ordinary shares exercise (in Shares) | 26,068,281 | |||
Carrying amount of warrants (in Dollars) | $ 130,000 | |||
Over-Allotments [Member] | ||||
Public Offering (Details) [Line Items] | ||||
Number of units sold (in Shares) | 30,000,000 | |||
Purchase of additional units (in Shares) | 2,500,000 | |||
Class A Ordinary Shares [Member] | ||||
Public Offering (Details) [Line Items] | ||||
Ordinary share, par value | $ 0.0001 | $ 0.0001 | ||
Redeemable warrants | 0.1 | |||
Ordinary shares equals exceeds | 10 | |||
Shares redeemed (in Shares) | 26,068,281 | |||
Class A Ordinary Shares [Member] | Public Offering [Member] | ||||
Public Offering (Details) [Line Items] | ||||
Ordinary share, par value | 0.0001 | |||
Class A Ordinary Shares [Member] | Minimum [Member] | ||||
Public Offering (Details) [Line Items] | ||||
Ordinary shares equals exceeds | $ 18 |
Related Party Transactions (Det
Related Party Transactions (Details) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||
Jan. 13, 2023 | Jan. 03, 2023 | Aug. 01, 2022 | Jan. 31, 2021 | Nov. 30, 2020 | Mar. 31, 2023 | Mar. 31, 2022 | Dec. 31, 2022 | Dec. 31, 2020 | May 31, 2023 | Apr. 30, 2023 | |
Related Party Transactions (Details) [Line Items] | |||||||||||
Founder shares vesting, description | The Founder Shares are substantially identical to the Class A ordinary shares included in the Units sold in the Public Offering except that the Founder Shares automatically convert into Class A ordinary shares at the time of the initial Business Combination, or at any time prior thereto at the option of the holder, and are subject to certain transfer restrictions, as described in more detail below, and the Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then 12.5% on each of the attainment of Return to Shareholders (as defined in the agreement) exceeding 20%, 30%, 40% and 50%. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. | ||||||||||
Aggregate loan amount | $ 300,000 | ||||||||||
Issuance of unsecured promissory note | $ 1,000 | ||||||||||
Costs paid | $ 25,000 | ||||||||||
Principal amount | $ 2,000,000 | ||||||||||
Loan repaid | 30,000 | ||||||||||
Outstanding principal balance | 785,000 | $ 755,000 | |||||||||
Unpaid principal amount | $ 250,000 | ||||||||||
Valuations fair value | $ 572,000 | ||||||||||
Drawdown shares (in Shares) | 377,000 | ||||||||||
Equity amount | $ 377,000 | ||||||||||
Increase to the fair value | 32,000 | ||||||||||
Fair value | 604,000 | ||||||||||
Outstanding principal balance | 345,000 | ||||||||||
Borrowing amount | 300,000 | ||||||||||
Additional borrowing | 20,000 | ||||||||||
General and administrative expenses | 75,000 | $ 75,000 | |||||||||
Accrued liabilities | $ 50,000 | $ 0 | |||||||||
Private Placement Warrants [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Aggregate of shares (in Shares) | 5,566,667 | ||||||||||
Warrant price per share (in Dollars per share) | $ 1.5 | ||||||||||
Warrants purchase price | $ 8,350,000 | ||||||||||
Public Offering [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Notes payable amount | $ 199,000 | ||||||||||
Class A Ordinary Shares [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Price per share (in Dollars per share) | $ 12 | ||||||||||
Class A Ordinary Shares [Member] | Private Placement Warrants [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Price per share (in Dollars per share) | $ 11.5 | ||||||||||
Subsequent Event [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Borrowing amount | $ 300,000 | $ 300,000 | |||||||||
January 13, 2023 [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Principal amount | $ 250,000 | ||||||||||
Warrant price (in Dollars per share) | $ 1.5 | ||||||||||
Ordinary shares par value (in Dollars per share) | $ 0.0001 | ||||||||||
January 3, 2023 [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Principal amount | $ 3,000,000 | ||||||||||
January 3, 2023 [Member] | Warrant [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Warrant price (in Dollars per share) | $ 1.5 | ||||||||||
Outstanding notes payable amount | $ 949,000 | ||||||||||
January 3, 2023 [Member] | Class A Ordinary Shares [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Ordinary shares par value (in Dollars per share) | $ 0.0001 | ||||||||||
Founder Shares [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Related party costs | $ 25,000 | ||||||||||
Price per share (in Dollars per share) | $ 0.003 | ||||||||||
Aggregate shares issued (in Shares) | 7,500,000 | ||||||||||
Founder Shares [Member] | Over-Allotment Option [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Shares subject to forfeiture (in Shares) | 625,000 | ||||||||||
Founder Shares [Member] | Class B Ordinary Shares [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Purchase of ordinary shares (in Shares) | 7,187,500 | ||||||||||
Sponsor [Member] | Public Offering [Member] | |||||||||||
Related Party Transactions (Details) [Line Items] | |||||||||||
Costs paid | $ 49,000 |
Related Party Transactions (D_2
Related Party Transactions (Details) - Schedule of of level 3 fair value measurements inputs at their measurement dates | Sep. 30, 2022 USD ($) |
Related Party Transactions (Details) - Schedule of of level 3 fair value measurements inputs at their measurement dates [Line Items] | |
Extension Promissory Notes - related party | $ 604,000 |
Total fair value | 604,000 |
Level 1 [Member] | |
Related Party Transactions (Details) - Schedule of of level 3 fair value measurements inputs at their measurement dates [Line Items] | |
Extension Promissory Notes - related party | |
Total fair value | |
Level 2 [Member] | |
Related Party Transactions (Details) - Schedule of of level 3 fair value measurements inputs at their measurement dates [Line Items] | |
Extension Promissory Notes - related party | |
Total fair value | |
Level 3 [Member] | |
Related Party Transactions (Details) - Schedule of of level 3 fair value measurements inputs at their measurement dates [Line Items] | |
Extension Promissory Notes - related party | 604,000 |
Total fair value | $ 604,000 |
Related Party Transactions (D_3
Related Party Transactions (Details) - Schedule of the following table provides quantitative information regarding the Level 3 fair value measurements | 3 Months Ended |
Mar. 31, 2023 $ / shares | |
Schedule of the following table provides quantitative information regarding the Level 3 fair value measurements [Abstract] | |
Exercise price | $ 1.5 |
Unobserved Deal-Scenario Stock price | $ 3.63 |
Option term (in years) | 5 years |
Volatility | 3% |
Implied Probability of Merger Success | 60% |
Accounting for Warrant Liabil_3
Accounting for Warrant Liability (Details) - shares | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Accounting for Warrant Liability (Details) [Line Items] | ||
Warrants outstanding | 15,566,667 | 11,221,954 |
Contingent redeemable warrants | 4,344,714 | |
Ordinary shares exercise | 26,068,281 | |
Public Warrants [Member] | ||
Accounting for Warrant Liability (Details) [Line Items] | ||
Warrants outstanding | 5,655,286 | 10,000,000 |
Private Placement Warrants [Member] | ||
Accounting for Warrant Liability (Details) [Line Items] | ||
Warrants outstanding | 5,566,667 | 5,566,667 |
Accounting for Warrant Liabil_4
Accounting for Warrant Liability (Details) - Schedule of warrant liabilities that are measured at fair value on a recurring basis - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 |
Warrant Liabilities: | ||
Warrant liability | $ 2,357,000 | $ 467,000 |
Public Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | 1,188,000 | 300,000 |
Private Placement Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | 1,169,000 | 167,000 |
Quoted Prices in Active Markets (Level 1) [Member] | ||
Warrant Liabilities: | ||
Warrant liability | 1,188,000 | 300,000 |
Quoted Prices in Active Markets (Level 1) [Member] | Public Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | 1,188,000 | 300,000 |
Quoted Prices in Active Markets (Level 1) [Member] | Private Placement Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | ||
Significant Other Observable Inputs (Level 2) [Member] | ||
Warrant Liabilities: | ||
Warrant liability | 1,169,000 | 167,000 |
Significant Other Observable Inputs (Level 2) [Member] | Public Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | ||
Significant Other Observable Inputs (Level 2) [Member] | Private Placement Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | 1,169,000 | 167,000 |
Significant Other Unobservable Inputs (Level 3) [Member] | ||
Warrant Liabilities: | ||
Warrant liability | ||
Significant Other Unobservable Inputs (Level 3) [Member] | Public Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability | ||
Significant Other Unobservable Inputs (Level 3) [Member] | Private Placement Warrants [Member] | ||
Warrant Liabilities: | ||
Warrant liability |
Trust Account and Fair Value _3
Trust Account and Fair Value Measurement (Details) - USD ($) | Jan. 11, 2023 | Mar. 31, 2023 |
Fair Value Disclosures [Abstract] | ||
Deposited amount | $ 300,000,000 | |
Shareholders redeemed (in Shares) | 26,068,281 | |
Redeemed per share (in Dollars per share) | $ 10.167 | |
Redeemed value | $ 265,050,000 |
Trust Account and Fair Value _4
Trust Account and Fair Value Measurement (Details) - Schedule of fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets or liabilities | Dec. 31, 2022 USD ($) |
Carrying Value [Member] | |
Assets: | |
Money Market Fund | $ 304,675,000 |
Total | 304,675,000 |
Quoted Price in Active Markets (Level 1) [Member] | |
Assets: | |
Money Market Fund | 304,675,000 |
Total | $ 304,675,000 |
Shareholders_ Deficit (Details)
Shareholders’ Deficit (Details) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Shareholders’ Deficit (Details) [Line Items] | ||
Ordinary shares total | 550,000,000 | |
Business combination, description | The Founder Shares are subject to vesting as follows: 50% upon the completion of a Business Combination and then an additional 12.5% on the attainment of each of a series of certain “shareholder return” targets exceeding 20%, 30%, 40% and 50%, as further defined in the agreement. Certain events, as defined in the agreement, could trigger an immediate vesting under certain circumstances. Founder Shares that do not vest within an eight-year period from the closing of the Business Combination will be cancelled. | |
Ordinary shares subject to possible redemption | 3,931,719 | 30,000,000 |
Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Preferred stock, shares issued | ||
Preferred stock, shares outstanding | ||
Class A Ordinary Shares [Member] | ||
Shareholders’ Deficit (Details) [Line Items] | ||
Ordinary shares, authorized | 500,000,000 | 500,000,000 |
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, issued | 0 | 0 |
Ordinary shares, outstanding | 0 | 0 |
Ordinary shares subject to possible redemption | 3,931,719 | 30,000,000 |
Class B Ordinary Shares [Member] | ||
Shareholders’ Deficit (Details) [Line Items] | ||
Ordinary shares, authorized | 50,000,000 | 50,000,000 |
Ordinary shares, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 |
Ordinary shares, issued | 7,500,000 | 7,500,000 |
Ordinary shares, outstanding | 7,500,000 | 7,500,000 |
Commitments and Contingencies (
Commitments and Contingencies (Details) | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Federal excise tax percentage | 1% |
Fair market value percentage | 1% |